Future studies will further characterize the therapeutic potential of ADI-TRAIL such as its ability to penetrate tumors with dense stroma (e.g. pancreatic ductal adenocarcinoma). The gene discussed is TNFSF10; the disease is pancreatic ductal adenocarcinoma.